Thu, Oct 30, 2014, 2:24 PM EDT - U.S. Markets close in 1 hr 36 mins


% | $
Quotes you view appear here for quick access.

Gilead Sciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • sschatzi33 sschatzi33 Jun 5, 2007 3:33 PM Flag

    how low will GILD go?

    I don't want to be too harsh on you, but 4 out of 64 is 1 16th or .0625 or 6.25%. In the good ol' days we called it a teeny. Maybe you should let your wife handle the finances.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • OK, so you caught me on a typo.

      You are conveniently ignoring the fact that liver toxicity problems with ambrisentan numbered 4 patients out of 64 tested.

      While for you "in the good ol' days we called it a teeny" the FDA will not call it that. You are a fool to believe the FDA will overlook those stats.

      Do you know that FDA asked for Pfizer's Bextra to be pulled out of the market due to adverse events at rates 100 times lower than ambrisentan?

      Ambrisentan does not have the number of patients in the safety data base that FDA needs for approval. It will get an approvable at best.

113.95+3.23(+2.92%)2:24 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.